The import of penicillins or streptomycins not in dosage forms to the US is forecasted to decrease steadily from 2024 to 2028, starting at 216.68 thousand kilograms in 2024 and dropping to 203.15 thousand kilograms in 2028. Assuming the same data for 2023 does not exist, one can observe a year-on-year decline, with percentages showing slight reductions annually.
- 2024 to 2025: 1.61% decrease
- 2025 to 2026: 1.60% decrease
- 2026 to 2027: 1.59% decrease
- 2027 to 2028: 1.59% decrease
The compound annual growth rate (CAGR) over the five-year forecasted period is approximately a continuous decline of 1.61% annually.
Future trends to watch for include potential market influences such as supply chain disruptions, advances in alternative antibiotics, and regulatory changes impacting imports. Monitoring these factors could be critical in adapting to changes in demand or supply constraints shaping market dynamics.
